Juris Hmelnickis
Vorstandsvorsitzender bei GRINDEKS
Aktive Positionen von Juris Hmelnickis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GRINDEKS | Vorstandsvorsitzender | 04.02.2020 | - |
| Corporate Officer/Principal | 01.01.2010 | 04.02.2020 | |
Kalceks AS
 Kalceks AS Pharmaceuticals: MajorHealth Technology Part of Grindeks AS, Kalceks AS is a pharmaceutical company based in Riga, Latvia. Kalceks manufactures pharmaceutical products. The Latvian company was founded in 1920. Egils Kopstals has been the CEO of the company since 2020. Kalceks was acquired by Grindeks AS on May 09, 2005. | Corporate Officer/Principal | 18.02.2020 | - |
| Vorstandsvorsitzender | 01.01.2014 | 18.02.2020 |
Karriereverlauf von Juris Hmelnickis
Ausbildung von Juris Hmelnickis
| University of Latvia | Graduate Degree |
| Riga Technical University | Graduate Degree |
Statistik
International
| Lettland | 4 |
| 2 |
Operativ
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Grindeks AS
 Grindeks AS Pharmaceuticals: MajorHealth Technology Grindeks AS produces pharmaceutical, medical, and phytochemical medicine. It engages in the research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The company specializes in the heart and cardiovascular, central nervous system, and anti-cancer medication therapeutic groups. Grindeks was founded in 1946 and is headquartered in Riga, Latvia. | Health Technology |
Kalceks AS
Kalceks AS Pharmaceuticals: MajorHealth Technology Part of Grindeks AS, Kalceks AS is a pharmaceutical company based in Riga, Latvia. Kalceks manufactures pharmaceutical products. The Latvian company was founded in 1920. Egils Kopstals has been the CEO of the company since 2020. Kalceks was acquired by Grindeks AS on May 09, 2005. | Health Technology |
- Börse
- Insiders
- Juris Hmelnickis
- Erfahrung
